Evidence map›Paper›PMID 38638968›Full record

ArticleHeliyon2024

Optimizing cellulose fraction for enhanced utility: Comparative pre-treatment of

A Lazaro-Romero, S M Contreras-Ramos, M Dehonor-Gómez, J M Rojas-García, L Amaya-Delgado

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

A Lazaro-RomeroUnidad de Tecnología Ambiental, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C. (CIATEJ), Av. Normalistas #800, Col. Colinas de la Normal, Guadalajara, Jalisco, Mexico.
S M Contreras-RamosUnidad de Tecnología Ambiental, Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco A.C. (CIATEJ), Av. Normalistas #800, Col. Colinas de la Normal, Guadalajara, Jalisco, Mexico.
M Dehonor-GómezCentro de Tecnología Avanzada A.C. (CIATEQ), Circuito de la Industria Poniente Lote 11, Manzana 3, No. 11, Col. Parque Industrial Exhacienda Doña Rosa, Lerma, Estado de México, Mexico.
J M Rojas-GarcíaCentro de Tecnología Avanzada A.C. (CIATEQ), Circuito de la Industria Poniente Lote 11, Manzana 3, No. 11, Col. Parque Industrial Exhacienda Doña Rosa, Lerma, Estado de México, Mexico.
L Amaya-DelgadoUnidad de Biotecnología Industrial, CIATEJ, Camino Arenero 1227, Col. El Bajío, Zapopan, Jalisco, México.
Centro de Investigación en Materiales Avanzados · MXCentro de Investigación y Asistencia en Tecnología y Diseño del Estado de JaliscoCentro de Investigación y Proyectos en Ambiente y Desarrollo · MXCIATEQSecretaría de Salud de Jalisco · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent decades, natural fibers have emerged as an alternative to synthetic fibers due to their renewable nature, lower environmental impact, and comparable strength properties. Agave bagasse, a byproduct of agave juice extraction in Mexico, stands out for its potential in various industrial applications, notably biocomposite production. Bagasse is rich in cellulose, along with hemicellulose and lignin. Cellulose is the most suitable to be converted into valuable products, and it is versatile, renewable, and biodegradable. An effective pre-treatment is crucial to enrich its fraction. This study aims to determine the optimal pre-treatment conditions for the agave bagasse. Three different pre-treatments were tested, acid (H

Indexed as

Agave bagasseCelluloseChemical analysisSurface treatments

Identifiers

PMID38638968
PMCPMC11024549
OpenAlexW4394010270

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.